pharmanewsdaily
1509 posts
Deciphera gets Qinlock FDA approval for fourth-line advanced GIST
Qinlock FDA approval : Deciphera Pharmaceuticals has been granted approval from the US Food and Drug Administration (FDA)…
May 17, 2020
Roche launches v-TAC blood gas digital solution
Swiss healthcare company Roche has launched a new blood gas digital solution called Roche v-TAC, which is said…
May 16, 2020
Thermo Fisher, WuXi, Mayo Clinic to develop total antibodies Covid-19 test
US life sciences company Thermo Fisher Scientific said that it will collaborate with China-based WuXi Diagnostics and Mayo…
May 15, 2020
FDA rejects Blueprint’s NDA for AYVAKIT for treatment of fourth-line GIST
Blueprint Medicines said that the US Food and Drug Administration (FDA) has rejected its new drug application (NDA)…
May 15, 2020
FDA rejects Blueprint’s NDA for AYVAKIT for treatment of fourth-line GIST
Blueprint Medicines said that the US Food and Drug Administration (FDA) has rejected its new drug application (NDA) for AYVAKIT (avapritinib) for the treatment of fourth-line gastrointestinal stromal tumor (GIST). The US precision therapy company received a complete response letter (CRL) from the FDA in this connection. Blueprint Medicines was seeking FDA approval for avapritinib […]
May 15, 2020
Sorrento Therapeutics says STI-1499 fully inhibited SARS-CoV-2 virus
Sorrento Therapeutics said that STI-1499, its anti-SARS-CoV-2 antibody, showed 100% inhibition of SARS-CoV-2 virus infection in an in…
May 15, 2020
Rohatyn Group completes investment in Croatian CRO Optimapharm
The Rohatyn Group (TRG), a US asset management firm focusing on emerging markets, has completed an investment in…
May 13, 2020
Abbott gets FDA EUA for COVID-19 antibody blood test on Alinity i system
Abbott has been granted emergency use authorization (EUA) from the US Food and Drug Administration (FDA) for its…
May 12, 2020
HKBU-led researchers develop EBV drug for nasopharyngeal cancer
A research team headed by Hong Kong Baptist University (HKBU) claims to have developed a novel anti-Epstein-Barr virus…
May 12, 2020
AbbVie wraps up $63bn acquisition of Irish drugmaker Allergan
US biopharma company AbbVie has wrapped up its previously announced $63 billion acquisition of Irish drugmaker Allergan following…
May 9, 2020